[ Price : $8.95]
Travere Therapeutics says confirmatory trial data for accelerated approval therapy Filspari (sparsentan) will form the basis of a ...[ Price : $8.95]
Three Hogan Lovells attorneys analyze a recent FDA guidance on using the ISO 10993-1 international standard for medical device bio...[ Price : $8.95]
An NPR report says FDA has received nearly 500 complaints about mental health issues patients associate with using semaglutide dru...[ Price : $8.95]
FDA accepts for priority review a Merck supplemental BLA for Keytruda (pembrolizumab) and its combination use with external beam r...[ Price : $8.95]
FDA grants orphan drug designation to Puma Biotechnologys small cell lung cancer investigative drug aliserib.[ Price : $8.95]
Federal Register notice: FDA reopens the comment period for the 4/4 notice entitled In-Home Disposal Systems for Opioid Analgesics...[ Price : $8.95]
In an unusual move, FDA issues a statement about recent agency inspections at Novo Nordisks Clayton, NC manufacturing facility to ...[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Considerations for the Conduct of Clinical Trials of Medica...